Patent · US Active

Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators

US9765067B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Christopher M. Adams · Arlington, US
David B. Belanger · Cambridge, US
Doug Bevan · Chelmsford, US
Takeru Ehara · Tsukuba, JP
Luciana Ferrara · Stoughton, US
Nan Ji · Arlington, US
Donglei Liu · Cambridge, US
Erik Meredith · Cambridge, US
Muneto Mogi · Waltham, US
James J. Powers · Waltham, US
Ganesh Prasanna · Acton, US
Mitsunori Kato · Cambridge, US

Key dates

Filing date	Jul 2, 2015
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Jul 2, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.